Maximus, Inc. (NYSE:MMS) Shares Purchased by Trexquant Investment LP

Trexquant Investment LP grew its holdings in shares of Maximus, Inc. (NYSE:MMSFree Report) by 19.8% during the fourth quarter, Holdings Channel reports. The firm owned 176,003 shares of the health services provider’s stock after acquiring an additional 29,073 shares during the quarter. Trexquant Investment LP’s holdings in Maximus were worth $13,139,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of MMS. Headlands Technologies LLC acquired a new stake in Maximus during the fourth quarter worth about $290,000. Franklin Resources Inc. grew its holdings in shares of Maximus by 21.8% during the fourth quarter. Franklin Resources Inc. now owns 6,176 shares of the health services provider’s stock valued at $461,000 after purchasing an additional 1,104 shares during the last quarter. Meeder Asset Management Inc. acquired a new stake in shares of Maximus during the 4th quarter worth approximately $1,407,000. Arrowstreet Capital Limited Partnership raised its position in shares of Maximus by 108.5% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 84,309 shares of the health services provider’s stock worth $6,294,000 after purchasing an additional 43,864 shares during the period. Finally, Pictet Asset Management Holding SA lifted its holdings in shares of Maximus by 8.6% in the 4th quarter. Pictet Asset Management Holding SA now owns 8,563 shares of the health services provider’s stock worth $639,000 after purchasing an additional 676 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Maximus

In other news, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jan Madsen sold 2,439 shares of the business’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

MMS has been the subject of a number of recent research reports. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd.

View Our Latest Stock Analysis on MMS

Maximus Stock Performance

MMS opened at $68.64 on Wednesday. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The business’s 50 day moving average is $69.57 and its 200-day moving average is $77.51. The stock has a market cap of $3.88 billion, a PE ratio of 14.76 and a beta of 0.71. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97.

Maximus (NYSE:MMSGet Free Report) last announced its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were given a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.75%. Maximus’s dividend payout ratio is presently 25.81%.

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Recommended Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.